Literature DB >> 28050048

Editorial: "Lean" NAFLD: Metabolic Obesity with Normal BMI… Is It in the Genes?

Curtis K Argo1, Zachary H Henry1.   

Abstract

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease. "Lean" NAFLD represents a patient subpopulation with hepatic steatosis evident on imaging with normal BMI. This paper by Feldman and Eder et al. illustrates the mild but clear metabolic differences and genetic connections in Caucasian lean NAFLD patients compared with obese NAFLD and healthy controls. Their findings highlight key similarities of lean and obese NAFLD compared with lean healthy subjects. This paper characterizes "lean" NAFLD as a unique phenotype with specific genetic associations deserving of further investigation in the greater scheme of elucidating the pathophysiology of fatty liver.

Entities:  

Mesh:

Year:  2017        PMID: 28050048     DOI: 10.1038/ajg.2016.527

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  13 in total

1.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

2.  Clinical, anthropometric, biochemical, and histological characteristics of nonobese nonalcoholic fatty liver disease patients of Bangladesh.

Authors:  Shahinul Alam; Utpal Das Gupta; Mahbubul Alam; Jahangir Kabir; Ziaur Rahman Chowdhury; A K M Khorshed Alam
Journal:  Indian J Gastroenterol       Date:  2014-07-15

3.  Nonalcoholic fatty liver disease and metabolic syndrome: Shared genetic basis of pathogenesis.

Authors:  Silvia Sookoian; Carlos J Pirola
Journal:  Hepatology       Date:  2016-08-24       Impact factor: 17.425

4.  The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease.

Authors:  Yaron Rotman; Christopher Koh; Joseph M Zmuda; David E Kleiner; T Jake Liang
Journal:  Hepatology       Date:  2010-09       Impact factor: 17.425

5.  Cross-talk between branched-chain amino acids and hepatic mitochondria is compromised in nonalcoholic fatty liver disease.

Authors:  Nishanth E Sunny; Srilaxmi Kalavalapalli; Fernando Bril; Timothy J Garrett; Manisha Nautiyal; Justin T Mathew; Caroline M Williams; Kenneth Cusi
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-06-09       Impact factor: 4.310

6.  Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population.

Authors:  Ren-Nan Feng; Shan-Shan Du; Cheng Wang; Yan-Chuan Li; Li-Yan Liu; Fu-Chuan Guo; Chang-Hao Sun
Journal:  World J Gastroenterol       Date:  2014-12-21       Impact factor: 5.742

7.  Clinical and Metabolic Characterization of Lean Caucasian Subjects With Non-alcoholic Fatty Liver.

Authors:  Alexandra Feldman; Sebastian K Eder; Thomas K Felder; Lyudmyla Kedenko; Bernhard Paulweber; Andreas Stadlmayr; Ursula Huber-Schönauer; David Niederseer; Felix Stickel; Simon Auer; Elisabeth Haschke-Becher; Wolfgang Patsch; Christian Datz; Elmar Aigner
Journal:  Am J Gastroenterol       Date:  2016-08-16       Impact factor: 10.864

Review 8.  Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.

Authors:  Zobair M Younossi; Aaron B Koenig; Dinan Abdelatif; Yousef Fazel; Linda Henry; Mark Wymer
Journal:  Hepatology       Date:  2016-02-22       Impact factor: 17.425

9.  Nonalcoholic fatty liver disease in lean individuals in the United States.

Authors:  Zobair M Younossi; Maria Stepanova; Francesco Negro; Shareh Hallaji; Youssef Younossi; Brian Lam; Manirath Srishord
Journal:  Medicine (Baltimore)       Date:  2012-11       Impact factor: 1.889

10.  Adipose Tissue Dysfunction and Altered Systemic Amino Acid Metabolism Are Associated with Non-Alcoholic Fatty Liver Disease.

Authors:  Sulin Cheng; Petri Wiklund; Reija Autio; Ronald Borra; Xiaowei Ojanen; Leiting Xu; Timo Törmäkangas; Markku Alen
Journal:  PLoS One       Date:  2015-10-06       Impact factor: 3.240

View more
  5 in total

1.  Is metabolic syndrome responsible for the progression from NAFLD to NASH in non-obese patients?

Authors:  Takumi Kawaguchi; Takuji Torimura
Journal:  J Gastroenterol       Date:  2019-11-28       Impact factor: 7.527

2.  Whole-Exome Sequencing Identifies a Variant in Phosphatidylethanolamine N-Methyltransferase Gene to be Associated With Lean-Nonalcoholic Fatty Liver Disease.

Authors:  Govardhan Bale; Ravikanth V Vishnubhotla; Sasikala Mitnala; Mithun Sharma; Rao N Padaki; Smita C Pawar; Reddy N Duvvur
Journal:  J Clin Exp Hepatol       Date:  2019-02-11

3.  Risk for development of severe liver disease in lean patients with nonalcoholic fatty liver disease: A long-term follow-up study.

Authors:  Hannes Hagström; Patrik Nasr; Mattias Ekstedt; Ulf Hammar; Per Stål; Rolf Hultcrantz; Stergios Kechagias
Journal:  Hepatol Commun       Date:  2017-11-30

4.  Laboratory parameters in lean NAFLD: comparison of subjects with lean NAFLD with obese subjects without hepatic steatosis.

Authors:  Philipp Bernhardt; Wolfgang Kratzer; Julian Schmidberger; Tilmann Graeter; Beate Gruener
Journal:  BMC Res Notes       Date:  2018-02-06

5.  Association between the hyperuricemia and nonalcoholic fatty liver disease risk in a Chinese population: A retrospective cohort study.

Authors:  Chao Yang; Shujuan Yang; Weiwei Xu; Junhui Zhang; Wenguang Fu; Chunhong Feng
Journal:  PLoS One       Date:  2017-05-16       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.